![]() |
|
|
Vol. 291, Issue 3, 1038-1044, December 1999
Department of Cardiology (J.-Y.M., A.M., R.S.), Institute of
Pharmacology (S.S., T.U.), University of Kiel, Germany
Mibefradil is a selective T-type Ca2+ channel
blocker that exerts a potent vasodilating but weak inotropic action.
The present study compared mibefradil with traditional L-type
Ca2+ channel blockers in regard to the effects of chronic
oral administration on hemodynamics, contractility, and intracellular
Ca2+ handling in failing myocardium from postinfarction
rats. Male Wistar rats with ligation-induced myocardial infarction were
assigned to placebo or treatment with mibefradil (10 mg/kg/day),
verapamil (8 mg/kg/day), or amlodipine (4 mg/kg/day) by oral gavage
starting 7 days before the induction of myocardial infarction. Six
weeks after myocardial infarction, hemodynamic measurements were
performed in conscious animals. In addition, isometric force and free
[Ca2+]i were determined in isolated left
ventricular papillary muscles. Placebo-treated rats exhibited a
decreased mean atrial pressure, an increased left ventricular
end-diastolic pressure, and a reduced rate of pressure rise compared
with sham-operated animals. Mibefradil treatment significantly improved
all of these parameters, whereas both amlodipine and verapamil exerted
only minor effects.
-Adrenergic stimulation with isoproterenol (ISO)
enhanced contractility and Ca2+ availability in papillary
muscles from sham-operated rats, whereas the ISO-induced inotropic
effect in muscles from placebo-treated rats was severely blunted.
Chronic mibefradil treatment significantly improved the inotropic
response to ISO stimulation, although the Ca2+i
availability appeared to be less than in muscles from placebo-treated animals. In contrast, both verapamil and amlodipine did not restore the
inotropic and Ca2+i modulating effect of ISO in
remodeled myocardium. Thus, T-type Ca2+ current appears to
be of pathophysiological relevance in postischemic reperfused myocardium.
This article has been cited by other articles:
![]() |
X. Hu, S. P. Yu, J. L. Fraser, Z. Lu, M. E. Ogle, J.-A. Wang, and L. Wei Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 799 - 808. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Hu, J. Wang, J. Chen, R. Luo, A. He, X. Xie, and J. Li Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction Eur. J. Cardiothorac. Surg., March 1, 2007; 31(3): 438 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Min, Y. Yang, M. F. Sullivan, Q. Ke, K. L. Converso, Y. Chen, J. P. Morgan, and Y.-F. Xiao Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 361 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Min, M. F. Sullivan, X. Yan, X. Feng, V. Chu, J.-F. Wang, I. Amende, J. P. Morgan, K. D. Philipson, and T. G. Hampton Overexpression of Na+/Ca2+ exchanger gene attenuates postinfarction myocardial dysfunction Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2466 - H2471. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Min, Y. Yang, K. L. Converso, L. Liu, Q. Huang, J. P. Morgan, and Y.-F. Xiao Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats J Appl Physiol, January 1, 2002; 92(1): 288 - 296. [Abstract] [Full Text] [PDF] |
||||